MEPIRAPIM
外觀
![]() | |
法律規範狀態 | |
---|---|
法律規範 |
|
識別資訊 | |
| |
CAS號 | 2365542-29-4 |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
化學資訊 | |
化學式 | C19H27N3O |
摩爾質量 | 313.45 g·mol−1 |
3D模型(JSmol) | |
| |
|
MEPIRAPIM,化學名(4-甲基哌嗪-1-基)(1-戊基吲哚-3-基)甲酮(英語:(4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone),分子式C19H27N3O,是JWH-018的結構類似物,其中4-甲基哌嗪基團替代了萘基團[1],能作為大麻素,2013年在日本首次發現,一同檢出的還有FUBIMINA[2]。
參考文獻
[編輯]- ^ MEPIRAPIM. Cayman Chemical. [23 June 2015].
- ^ Uchiyama N, Shimokawa Y, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y. Two new synthetic cannabinoids, AM-2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivatives, 25H-NBOMe 3,4,5-trimethoxybenzyl analog, 25B-NBOMe, and 2C-N-NBOMe, identified in illegal products. Forensic Toxicology. January 2014, 32 (1): 105–115. S2CID 32599561. doi:10.1007/s11419-013-0217-2.